CliffBio
small molecule

ACEPHEN

ACETAMINOPHEN

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameACEPHEN
Active ingredientACETAMINOPHEN
Strength650MG
Dosage formSUPPOSITORY
RouteRECTAL
ModalitySmall molecule
Marketing statusDISCN

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.